March 12, 2021
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
FRIDAY, March 12, 2021 (HealthDay News) — Icosapent ethyl (IPE) can further reduce the risk for stroke for statin-treated patients with elevated triglycerides and the risk or evidence of atherosclerosis, according to a study presented at the American Stroke Association International Stroke Conference, held virtually from March 17 to 19. Deepak L. Bhatt, M.D., M.P.H.,...
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
FRIDAY, March 12, 2021 (HealthDay News) — A single course of teplizumab treatment delays progression to type 1 diabetes (T1D) and improves beta cell function in high-risk individuals, according to a study published in the March 3 issue of Science Translational Medicine. Emily K. Sims, M.D., from the Indiana University School of Medicine in Indianapolis,...